As of 4:00pm ET
| +0.04 / +1.81%|
The 1 analysts offering 12-month price forecasts for Brainstorm Cell Therapuetics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +122.22% increase from the last price of 2.25.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.